Biomaterials and stem cells for tissue engineering

Expert Opinion on Biological Therapy

Volumn 13, Issue 4, 2013, Pages 527-540

  Zhang, Zhanpeng ^a   Gupte, Melanie J ^a   Ma, Peter X ^b  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

Drug delivery; Growth factor; Nanofibrous scaffold; Phase separation; Stem cell; Surface modification; Tissue engineering

Indexed keywords

AGGRECAN; BIOMATERIAL; BONE SIALOPROTEIN; CALCIUM PHOSPHATE; COLLAGEN TYPE 2; GROWTH FACTOR; HYDROXYAPATITE; MACROGOL; MOLECULAR SCAFFOLD; NANOCOMPOSITE; NANOFIBER; OSTEOCALCIN; OSTEOGENIC PROTEIN 1; POLY(ORTHO ESTER); POLYALPHA HYDROXY ACID; POLYANHYDRIDE; POLYCAPROLACTONE; POLYGLACTIN; POLYGLYCOLIC ACID; POLYLACTIC ACID; POLYURETHAN; POROUS POLYMER; TISSUE SCAFFOLD; TRANSCRIPTION FACTOR SOX9; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

AMNIOTIC FLUID CELL; BIOLOGICAL ACTIVITY; BLOOD VESSEL GRAFT; BONE DEVELOPMENT; BONE MARROW; BONE MINERALIZATION; BONE REGENERATION; BONE TISSUE; CARTILAGE; CELL ADHESION; CELL DIFFERENTIATION; CELL FUNCTION; CELL PROLIFERATION; CELL REGENERATION; CHEMICAL COMPOSITION; CHEMICAL MODIFICATION; CHONDROGENESIS; COMPOSITE MATERIAL; DENTIN; ELECTROSPINNING; EMBRYONIC STEM CELL; EXTRACELLULAR MATRIX; HUMAN; MESENCHYMAL STEM CELL; MICROENVIRONMENT; NANOTECHNOLOGY; NONHUMAN; ODONTOBLAST; OSSIFICATION; PHASE SEPARATION; REVIEW; SMOOTH MUSCLE FIBER; STEM CELL NICHE; TISSUE ENGINEERING; TISSUE REGENERATION; TOOTH PULP; VASCULAR TISSUE; ANIMAL; CHEMISTRY; CYTOLOGY; PHYSIOLOGY; PROCEDURES; REGENERATION; STEM CELL; SURFACE PROPERTY;

ANIMALS; BIOCOMPATIBLE MATERIALS; CELL DIFFERENTIATION; HUMANS; REGENERATION; STEM CELL NICHE; STEM CELLS; SURFACE PROPERTIES; TISSUE ENGINEERING;

EID: 84879565497     PISSN: 14712598     EISSN: None     Source Type: Journal    
DOI: 10.1517/14712598.2013.756468     Document Type: Review

References (113)

1. Langer R, Vacanti JP. Tissue engineering. Science 1993;260(5110):920-6
2. De Coppi P, Bartsch Jr G, Siddiqui MM, et al. Isolation of amniotic stem cell lines with potential for therapy. Nat Biotechnol 2007;25(1):100-6
3. Saltzman WM, Olbricht WL. Building drug delivery into tissue engineering. Nat Rev Drug Discov 2002;1(3):177-86
4. Ma PX. Biomimetic materials for tissue engineering. Adv Drug Deliv Rev 2008;60(2):184-98
5. Odorico JS, Kaufman DS, Thomson JA. Multilineage differentiation from human embryonic stem cell lines. Stem Cells 2001;19(3):193-204
6. Pittenger MF, Mackay AM, Beck SC, et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999;284(5411):143-7
7. Varghese S, Elisseeff J, Hwang NS. Controlled differentiation of stem cells. Adv Drug Deliv Rev 2008;60(2):199-214
8. Mitragotri S, Lahann J. Physical approaches to biomaterial design. Nat Mater 2009;8(1):15-23
9. Altman GH, Diaz F, Jakuba C, et al. Silk-based biomaterials. Biomaterials 2003;24(3):401-16
10. Kloxin AM, Kasko AM, Salinas CN, Anseth KS. Photodegradable hydrogels for dynamic tuning of physical and chemical properties. Science 2009;324(5923):59-63
11. Luo Y, Shoichet MS. A photolabile hydrogel for guided three-dimensional cell growth and migration. Nat Mater 2004;3(4):249-54
12. Salinas CN, Anseth KS. The enhancement of chondrogenic differentiation of human mesenchymal stem cells by enzymatically regulated RGD functionalities. Biomaterials 2008;29(15):2370-7
13. Benoit DSW, Schwartz MP, Durney AR, Anseth KS. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater 2008;7(10):816-23
14. Ma PX. Scaffolds for tissue fabrication. Mater Today 2004;7(5):30-40
15. Engler A, Sen S, Sweeney H, Discher D. Matrix elasticity directs stem cell lineage specification. Cell 2006;126(4):677-89
16. Mizuno M, Shindo M, Kobayashi D, et al. Osteogenesis by bone marrow stromal cells maintained on type I collagen matrix gels in vivo. Bone 1997;20(2):101
17. Ma PX. Tissue engineering. In: Kroschvitz JI, editor. Encyclopedia of polymer science and technology. 3rd edition. John Wiley & Sons; Hoboken, NJ; 2004
18. Zhang R, Ma PX. Processing of polymer scaffolds: Phase separation. In: Atala A, Lanza R, editors. Methods of tissue engineering. Academic Press, San Diego; 2001
19. Pachence JM, Kohn J. Chapter 22-Biodegradable polymers. In: Lanza R, Langer R, Vacanti JP, editors. Principles of tissue engineering. 2nd edition. Academic Press, San Diego; 2000. p. 263-77
20. Rezwan K, Chen QZ, Blaker JJ, Boccaccini ARJ. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006;27(18):3413-31
21. Ma PX, Langer R. Degradation, structure and properties of fibrous poly(glycolic acid) scaffolds for tissue engineering. In: Mikos AG, editor. Polymers in medicine and pharmacy. Materials Research Society, Pittsburgh, PA; 1995. p. 99-104
22. Reed AM, Gilding DK. Biodegradable polymers for use in surgery-poly (glycolic)/poly(lactic acid) homo and copolymers: 2. In vitro degradation. Polymer (Guildf) 1981;22(4):494-8
23. Zhang R, Ma PX. Degradation behavior of porous poly (alpha-hydroxy acids)/hydroxyapatite composite scaffolds. Polymer Preprints 2000;41(2):1618-19
24. Eling B, Gogolewski S, Pennings AJ. Biodegradable materials of poly(l-lactic acid): 1. Melt-spun and solution-spun fibres. Polymer (Guildf) 1982;23(11):1587-93
25. Pitt CG, Gratzl MM, Kimmel GL. Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo. Biomaterials 1981;2(4):215-20
26. Miller ND, Williams DF. On the biodegradation of poly-beta- hydroxybutyrate (PHB) homopolymer and poly-beta-hydroxybutyrate-hydroxyvalerate copolymers. Biomaterials 1987;8(2):129-37
27. Sokolsky-Papkov M, Agashi K, Shakesheff K, Domb AJ. Polymer carriers for drug delivery in tissue engineering. Adv Drug Deliv Rev 2007;59(4-5):187-206
28. Bonzani IC, Adhikari R, Houshyar S, et al. Synthesis of two-component injectable polyurethanes for bone tissue engineering. Biomaterials 2007;28(3):423-33
29. Guelcher SA, Srinivasan A, Dumas JE, et al. Synthesis, mechanical properties, biocompatibility, and biodegradation of polyurethane networks from lysine polyisocyanates. Biomaterials 2008;29(12):1762-75
30. Gunatillake P, Mayadunne R, Adhikari R. Recent developments in biodegradable synthetic polymers. In: El-Gewely MR, editor. Biotechnology annual review. Elsevier, Amsterdam, Netherlands; 2006. p. 301-47
31. Leong KW, Kost J, Mathiowitz E, Langer R. Polyanhydrides for controlled release of bioactive agents. Biomaterials 1986;7(5):364-71
32. Choi NS, Heller J, inventors; Alza Corp. (Palo Alto, CA) assignee. Drug delivery devices manufactured from poly (orthoesters) and poly(orthocarbonates). US4093709; 1978
33. Elisseeff J, McIntosh W, Fu K, et al. Controlled-release of IGF-I and TGF-beta1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res 2001;19(6):1098-104
34. Anderson DG, Levenberg S, Langer R. Nanoliter-scale synthesis of arrayed biomaterials and application to human embryonic stem cells. Nat Biotechnol 2004;22(7):863-6
35. Zhang R, Ma PX. Poly(alpha-hydroxyl acids)/hydroxyapatite porous composites for bone-tissue engineering. I. Preparation and morphology. J Biomed Mater Res 1999;44(4):446-55
36. Liu X, Ma PX. Polymeric scaffolds for bone tissue engineering. Ann Biomed Eng 2004;32(3):477-86
37. Woo KM, Chen VJ, Ma PX. Nano-fibrous scaffolding architecture selectively enhances protein adsorption contributing to cell attachment. J Biomed Mater Res A 2003;67(2):531-7
38. Hu J, Liu X, Ma PX. Induction of osteoblast differentiation phenotype on poly(l-lactic acid) nanofibrous matrix. Biomaterials 2008;29(28):3815-21
39. Zhang R, Ma PX. Synthetic nano-fibrillar extracellular matrices with predesigned macroporous architectures. J Biomed Mater Res 2000;52(2):430-8
40. Chen VJ, Smith LA, Ma PX. Bone regeneration on computer-designed nano-fibrous scaffolds. Biomaterials 2006;27(21):3973-9
41. Liu X, Ma PX. Phase separation, pore structure, and properties of nanofibrous gelatin scaffolds. Biomaterials 2009;30(25):4094-103
42. Ma PX, Zhang R. Synthetic nano-scale fibrous extracellular matrix. J Biomed Mater Res 1999;46(1):60-72
43. Chen VJ, Ma PX. Nano-fibrous poly(L-lactic acid) scaffolds with interconnected spherical macropores. Biomaterials 2004;25(11):2065-73
44. Chen VJ, Ma PX. The effect of surface area on the degradation rate of nano-fibrous poly(l-lactic acid) foams. Biomaterials 2006;27(20):3708-15
45. Liu X, Ma PX. The nanofibrous architecture of poly(l-lactic acid)-based functional copolymers. Biomaterials 2010;31(2):259-69
46. Wei G, Ma PX. Partially nanofibrous architecture of 3D tissue engineering scaffolds. Biomaterials 2009;30(32):6426-34
47. Hu J, Sun X, Ma PX. Porous nanofibrous PLLA scaffolds for vascular tissue engineering. Biomaterials 2010;31(31):7971-7
48. Ma H, Hu J, Ma PX. Polymer scaffolds for small-diameter vascular tissue engineering. Adv Funct Mater 2010;20(17):2833-41
49. Wei G, Ma PX. Macroporous and nanofibrous polymer scaffolds and polymer/bone-like apatite composite scaffolds generated by sugar spheres. J Biomed Mater Res A 2006;78(2):306-15
50. Levenberg S, Rouwkema J, Macdonald M, et al. Engineering vascularized skeletal muscle tissue. Nat Biotechnol 2005;23(7):879-84
51. Zhang S, Huang Y, Yang X, et al. Gelatin nanofibrous membrane fabricated by electrospinning of aqueous gelatin solution for guided tissue regeneration. J Biomed Mater Res A 2009;90(3):671-9
52. Matthews JA, Wnek GE, Simpson DG, Bowlin GL. Electrospinning of collagen nanofibers. Biomacromolecules 2002;3(2):232-8
53. Yang F, Murugan R, Wang S, Ramakrishna S. Electrospinning of nano/micro scale poly(L-lactic acid) aligned fibers and their potential in neural tissue engineering. Biomaterials 2005;26(15):2603-10
54. Yoshimoto H, Shin YM, Terai H, Vacanti JP. A biodegradable nanofiber scaffold by electrospinning and its potential for bone tissue engineering. Biomaterials 2003;24(12):2077-82
55. Zong X, Ran S, Kim K-S, et al. Structure and morphology changes during in vitro degradation of electrospun poly (glycolide-co-lactide) nanofiber membrane. Biomacromolecules 2003;4(2):416-23
56. Reneker DH, Chun I. Nanometre diameter fibres of polymer, produced by electrospinning. Nanotechnology 1996;7(3):216-23
57. Jose MV, Thomas V, Xu Y, et al. Aligned bioactive multi-component nanofibrous nanocomposite scaffolds for bone tissue engineering. Macromol Biosci 2010;10(4):433-44
58. Nishida K. Corneal reconstruction with tissue-engineered cell sheets composed of autologous oral mucosal epithelium. N Engl J Med 2004;351(12):1187
59. Wang P, Hu J, Ma PX. The engineering of patient-specific, anatomically shaped, digits. Biomaterials 2009;30(14):2735-40
60. Nerem RM, Seliktar D. Vascular tissue engineering. Annu Rev Biomed Eng 2001;3:225-43
61. Germain L, Remy-Zolghadri M, Auger F. Tissue engineering of the vascular system: from capillaries to larger blood vessels. Med Biol Eng Comput 2000;38(2):232-40
62. Teebken OE, Haverich A. Tissue engineering of small diameter vascular grafts. Eur J Vasc Endovasc Surg 2002;23(6):475-85
63. Akao M, Sakatsume M, Aoki H, et al. In vitro mineralization in bovine tooth germ cell cultured with sintered hydroxyapatite. J Mater Sci 1993;4(6):569-74
64. Puleo DA, Holleran LA, Doremus RH, Bizios R. Osteoblast responses to orthopedic implant materials in vitro. J Biomed Mater Res 1991;25(6):711-23
65. Webster TJ, Ergun C, Doremus RH, et al. Specific proteins mediate enhanced osteoblast adhesion on nanophase ceramics. J Biomed Mater Res 2000;51(3):475-83
66. Ma PX, Zhang R. Microtubular architecture of biodegradable polymer scaffolds. J Biomed Mater Res 2001;56(4):469-77
67. Ma PX, Zhang R, Xiao G, Franceschi R. Engineering new bone tissue in vitro on highly porous poly(alpha-hydroxyl acids)/hydroxyapatite composite scaffolds. J Biomed Mater Res 2001;54(2):284-93
68. Wei G, Ma PX. Structure and properties of nano-hydroxyapatite/polymer composite scaffolds for bone tissue engineering. Biomaterials 2004;25(19):4749-57
69. Ma PX, Zhang R, inventors; The Regents of the University of Michigan, assignee. Porous composite materials. US6281257; 2001
70. Ma PX, Zhang R, inventors; The Regents of the University of Michigan, assignee. Porous composite materials. US6867240; 2005
71. Zhang R, Ma PX. Biomimetic polymer/apatite composite scaffolds for mineralized tissue engineering. Macromol Biosci 2004;4(2):100-11
72. Liu X, Smith LA, Hu J, Ma PX. Biomimetic nanofibrous gelatin/apatite composite scaffolds for bone tissue engineering. Biomaterials 2009;30(12):2252-8
73. He C, Xiao G, Jin X, et al. Electrodeposition on nanofibrous polymer scaffolds: rapid mineralization, tunable calcium phosphate composition and topography. Adv Funct Mater 2010;20:3568-76
74. Chen CS, Mrksich M, Huang S, et al. Geometric control of cell life and death. Science 1997;276(5317):1425-8
75. Nitschke M, Schmack G, Janke A, et al. Low pressure plasma treatment of poly (3-hydroxybutyrate): toward tailored polymer surfaces for tissue engineering scaffolds. J Biomed Mater Res 2002;59(4):632-8
76. Liu X, Won Y, Ma PX. Surface modification of interconnected porous scaffolds. J Biomed Mater Res A 2005;74(1):84-91
77. Liu X, Won Y, Ma PX. Porogen-induced surface modification of nano-fibrous poly (l-lactic acid) scaffolds for tissue engineering. Biomaterials 2006;27(21):3980-7
78. Liu X, Won Y, Ma PX. Surface engineering of nano-fibrous biodegradable poly(L-lactic acid) scaffolds for tissue engineering. MRS Proceedings 2004;2004:243-8
79. Schuldiner M, Yanuka O, Itskovitz-Eldor J, et al. Effects of eight growth factors on the differentiation of cells derived from human embryonic stem cells. Proc Natl Acad Sci USA 2000;97(21):11307-12
80. Langer R. Drug delivery and targeting. Nature 1998;392(6679 Suppl):5-10
81. Wei G, Pettway GJ, McCauley LK, Ma PX. The release profiles and bioactivity of parathyroid hormone from poly(lactic-co-glycolic acid) microspheres. Biomaterials 2004;25(2):345-52
82. Jeong B, Bae YH, Lee DS, Kim SW. Biodegradable block copolymers as injectable drug-delivery systems. Nature 1997;388(6645):860-2
83. Wei G, Jin Q, Giannobile WV, Ma PX. Nano-fibrous scaffold for controlled delivery of recombinant human PDGF-BB. J Control Release 2006;112(1):103-10
84. Wei G, Jin Q, Giannobile WV, Ma PX. The enhancement of osteogenesis by nano-fibrous scaffolds incorporating rhBMP-7 nanospheres. Biomaterials 2007;28(12):2087-96
85. Jin Q, Wei G, Lin Z, et al. Nanofibrous scaffolds incorporating PDGF-BB microspheres induce chemokine expression and tissue neogenesis in vivo. PLoS One 2008;3(3):e1729
86. Feng K, Sun H, Bradley MA, et al. Novel antibacterial nanofibrous PLLA scaffolds. J Control Release 2010;146(3):363-9
87. Hu J, Feng K, Liu XH, Ma PX. Chondrogenic and osteogenic differentiations of human bone marrow-derived mesenchymal stem cells on a nanofibrous scaffold with designed pore network. Biomaterials 2009;30(28):5061-7
88. Martin GR. Isolation of a pluripotent cell line from early mouse embryos cultured in medium conditioned by teratocarcinoma stem cells. Proc Natl Acad Sci USA 1981;78(12):7634-8
89. Smith LA, Liu X, Hu J, et al. Enhancing osteogenic differentiation of mouse embryonic stem cells by nanofibers. Tissue Eng Part A 2009;15(7):1855-64
90. Hwang NS, Varghese S, Zhang Z, Elisseeff J. Chondrogenic differentiation of human embryonic stem cell-derived cells in arginine-glycine-aspartate- modified hydrogels. Tissue Eng 2006;12(9):2695-706
91. Brown SE, Tong W, Krebsbach PH. The derivation of mesenchymal stem cells from human embryonic stem cells. Cells Tissues Organs 2009;189(1-4):256-60
92. Hu J, Smith LA, Feng K, et al. Response of human embryonic stem cell-derived mesenchymal stem cells to osteogenic factors and architectures of materials during in vitro osteogenesis. Tissue Eng Part A 2010;16(11):3507-14
93. Sun H, Feng K, Hu J, et al. Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials 2010;31(6):1133-9
94. Caplan AI. Mesenchymal stem cells. J Orthop Res 1991;9(5):641-50
95. Massa L, Aranachavez V. Odontoblasts: the cells forming and maintaining dentine. Int J Biochem Cell Biol 2004;36(8):1367-73
96. Wang J, Ma H, Jin X, et al. The effect of scaffold architecture on odontogenic differentiation of human dental pulp stem cells. Biomaterials 2011;32(31):7822-30
97. Wang J, Liu X, Jin X, et al. The odontogenic differentiation of human dental pulp stem cells on nanofibrous poly (l-lactic acid) scaffolds in vitro and in vivo. Acta Biomater 2010;6(10):3856-63
98. Tian H, Bharadwaj S, Liu Y, et al. Myogenic differentiation of human bone marrow mesenchymal stem cells on a 3D nanofibrous scaffold for bladder tissue engineering. Biomaterials 2010;31(5):870-7
99. Hu J, Xie C, Ma H, et al. Construction of vascular tissues with macro-porous nano-fibrous scaffolds and smooth muscle cells enriched from differentiated embryonic stem cells. PLoS ONE 2012;7(4):e35580
100. Zonari A, Novikoff S, Electo NRP, et al. Endothelial differentiation of human stem cells seeded onto electrospun polyhydroxybutyrate/ polyhydroxybutyrate-co-hydroxyvalerate fiber mesh. PLoS ONE 2012;7(4):e35422
101. Wingate K, Bonani W, Tan Y, et al. Compressive elasticity of three-dimensional nanofiber matrix directs mesenchymal stem cell differentiation to vascular cells with endothelial or smooth muscle cell markers. Acta Biomater 2012;8(4):1440-9
102. Caplan AI. Mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng 2005;11(7-8):1198-211
103. Zhang Y, Fan W, Ma Z, et al. The effects of pore architecture in silk fibroin scaffolds on the growth and differentiation of mesenchymal stem cells expressing BMP7. Acta Biomater 2010;6(8):3021-8
104. Sun H, Feng K, Hu J, et al. Osteogenic differentiation of human amniotic fluid-derived stem cells induced by bone morphogenetic protein-7 and enhanced by nanofibrous scaffolds. Biomaterials 2010;31(6):1133-9
105. Babensee J, McIntire L, Mikos A. Growth factor delivery for tissue engineering. Pharm Res 17(5):497-504
106. Schurr MJ, Foster KN, Centanni JM, et al. Phase I/II clinical evaluation of StrataGraft: a consistent, pathogen-free human skin substitute. J Trauma 2009;66(3):866-73
107. Matsumura G, Hibino N, Ikada Y, et al. Successful application of tissue engineered vascular autografts: clinical experience. Biomaterials 2003;24(13):2303-8
108. Raya-Rivera A, Esquiliano DR, Yoo JJ, et al. Tissue-engineered autologous urethras for patients who need reconstruction: an observational study. Lancet 2011;377(9772):1175-82
109. Marcacci M, Kon E, Moukhachev V, et al. Stem cells associated with macroporous bioceramics for long bone repair: 6-to 7-year outcome of a pilot clinical study. Tissue Eng 2007;13(5):947-55
110. Quarto R, Mastrogiacomo M, Cancedda R, et al. Repair of large bone defects with the use of autologous bone marrow stromal cells. N Engl J Med 2001;344(5):385-6
111. Morishita T, Honoki K, Ohgushi H, et al. Tissue engineering approach to the treatment of bone tumors: three cases of cultured bone grafts derived from patients' mesenchymal stem cells. Artif Organs 2006;30(2):115-18
112. Warnke PH, Springer ING, Wiltfang J, et al. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 2004;364(9436):766-70
113. Knight MAF, Evans GRD. Tissue engineering: progress and challenges. Plast Reconstr Surg 2004;114(2):26e-37e